A risk-benefit model shows that 5,248 children aged 5 to 11 will be killed by the Pfizer mRNA injection in order to save 45 children from dying of Coronavirus.
The Centre for Disease Control’s “Guidance” document describes 21 things that every health economics study in connection with vaccines must do. But the Food and Drug Administration’s (FDA) woeful risk-benefit analysis in connection with Pfizer’s Emergency Use Authorisation (EUA) application to inject children aged 5 to 11 with an experimental gene therapy violates many of these principles.
Today I want to focus on a single factor: the Number Needed to Vaccinate (NNTV). In four separate places the CDC Guidance document mentions the importance of coming up with a Number Needed to Vaccinate (NNTV). I did not recall seeing an NNTV in the FDA risk-benefit document. So I checked the FDA’s risk-benefit analysis again and sure enough, there was no mention of an NNTV.
Because the FDA failed to provide an NNTV, I will attempt to provide it here.
First a little background. The Number Needed to Treat (NNT) in order to prevent a single case, hospitalization, ICU admission, or death, is a standard way to measure the effectiveness of any drug. It’s an important tool because it enables policymakers to evaluate tradeoffs between a new drug, a different existing drug, or doing nothing. In vaccine research the equivalent term is Number Needed to Vaccinate (NNTV, sometimes also written as NNV) in order to prevent a single case, hospitalization, ICU admission, or death (those are 4 different NNTVs that one could calculate).
Pharma HATES talking about NNTV and they hate talking about NNTV even more when it comes to COVID-19 vaccines because the NNTV is so ridiculously high that this vaccine could not pass any honest risk-benefit analysis.
Indeed about a year ago I innocently asked on Twitter what the NNTV is for coronavirus vaccines.